❌

Normal view

There are new articles available, click to refresh the page.
Before yesterdayNews

Embattled Alzheimer’s Researcher Is Charged With Fraud

28 June 2024 at 18:05
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.

Β© Ilana Panich-Linsman for The New York Times

Hoau-Yan Wang’s work underpinned research into a diagnostic test for Alzheimer’s disease and simufilam, a drug in advanced clinical trials made by Cassava Sciences in Austin, Texas.

Gilead Shot Provides Total Protection From HIV in Trial of Young African Women

21 June 2024 at 19:30
An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.

Β© Aaron Ufumeli/EPA, via Shutterstock

A self-test for H.I.V. in Harare, Zimbabwe. The every-six-months injection was found to provide better protection than the current oral drug for what’s called pre-exposure prophylaxis, also taken as a daily pill.

How A.I. Is Revolutionizing Drug Development

17 June 2024 at 12:47
In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.

Chips in a container at Terray Therapeutics in Monrovia, Calif. Each of the custom-made chips has millions of minuscule wells for measuring drug screening reactions quickly and accurately.

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

Β© Noel Celis/Agence France-Presse β€” Getty Images

A seizure of the drug MDMA, known as Ecstasy or molly. It and other psychoactive drugs are still classified as illegal drugs with a potential for abuse.

Setback Deals Blow to Neuralink’s First Brain Implant Patient, but He Stays Upbeat

22 May 2024 at 11:57
Elon Musk’s first human experiment with a computerized brain device developed significant flaws, but the subject, who is paralyzed, has few regrets.

Β© Rebecca Noble for The New York Times

FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer

16 May 2024 at 16:59
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.

Β© Joe Buglewicz for The New York Times

Martha Warren, 65, of Westerly, R.I., found out last year that she had small cell lung cancer, and joined the tarlatamab clinical trial. She said she now feels as good as before her diagnosis.
❌
❌